Literature DB >> 1987921

Malignant mixed tumor (malignant ameloblastoma and fibrosarcoma) of the maxilla.

T Tanaka1, T Ohkubo, H Fujitsuka, N Tatematsu, N Oka, T Kojima, Y Morishita, N Yoshimi, H Mori.   

Abstract

We present a rare case of carcinosarcoma (malignant ameloblastoma and fibrosarcoma) of the left maxilla that developed in a 63-year-old Japanese man. The tumor recurred repeatedly despite multiple surgical removals, radiotherapy, and chemotherapy and led to progressive cachexia; the patient died after 3.8 years of hospitalization. Histopathologic examination revealed that the recurrent tumor was carcinosarcoma, which had progressed from malignant ameloblastoma with fibroma. An autopsy confirmed the diagnosis of malignant mixed tumor with lung metastasis of malignant ameloblastoma and fibrosarcoma.

Entities:  

Mesh:

Year:  1991        PMID: 1987921

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  5 in total

1.  Low-grade spindle-cell ameloblastic carcinoma: report of an unusual case with immunohistochemical findings and review of the literature.

Authors:  C Jindal; S Palaskar; H Kaur; M Shankari
Journal:  Curr Oncol       Date:  2010-10       Impact factor: 3.677

2.  Odontogenic carcinosarcoma of the mandible: a case report and review.

Authors:  Il-Kyu Kim; Sang-Pill Pae; Hyun-Young Cho; Hyun-Woo Cho; Ji-Hoon Seo; Dong-Hwan Lee; In-Shu Park
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-06-23

3.  Trends in Pediatric Ameloblastoma and its Management: A 15 year Indian Experience.

Authors:  Neelam N Andrade; Shweta P Shetye; Tejas S Mhatre
Journal:  J Maxillofac Oral Surg       Date:  2012-06-28

4.  Odontogenic carcinosarcoma - A rare case report with review of literature.

Authors:  Sumit Majumdar; Divya Uppala; Kotina Sreekanth; Bandi Alekhya
Journal:  J Oral Maxillofac Pathol       Date:  2022-02-28

5.  Mixed odontogenic tumors: A review of the clinicopathological and molecular features and changes in the WHO classification.

Authors:  Celeste Sánchez-Romero; Oslei Paes de Almeida; Ronell Bologna-Molina
Journal:  World J Clin Oncol       Date:  2021-12-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.